The global neuroendoscopy devices market is poised for robust growth over the next decade, according to recent market analysis. The market, valued at USD 214.5 million in 2023, is expected to reach USD 345 million by 2033, reflecting a compound annual growth rate (CAGR) of 4.9%. This growth trajectory follows a steady increase from 2018 to 2022, where the market expanded at an annual pace of 4.0%, reaching USD 204.4 million in 2022.
One of the primary factors driving the market’s expansion is the rising demand for neuroendoscopy devices, spurred by significant technological advancements. Developments in fiber optics and imaging have revolutionized neuroendoscopy, making endoscopic procedures more prevalent in neurological treatments. These advancements have led to enhanced precision and safety in surgeries, thereby increasing the adoption of neuroendoscopy devices globally.
Request a Sample Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-14926
Neuroendoscopy, a minimally invasive surgical procedure, allows neurosurgeons to access and treat areas of the brain that are otherwise difficult to reach. The procedure’s less invasive nature results in shorter recovery times and reduced risk of complications, making it an increasingly preferred option for both patients and healthcare providers.
The market’s growth is further bolstered by ongoing research and development efforts aimed at improving the functionality and efficacy of neuroendoscopy devices. Innovations such as high-definition imaging systems, flexible endoscopes, and advanced navigation tools are expected to propel the market forward, offering enhanced outcomes for patients undergoing neurological procedures.
As the global healthcare industry continues to evolve, the demand for advanced medical technologies like neuroendoscopy devices is anticipated to rise. The projected growth of the neuroendoscopy devices market underscores the importance of continued investment in medical technology to address the growing needs of neurological patients worldwide.
Key Takeaways:
- By 2033, the neuroendoscopy devices market in the United Kingdom is likely to expand, with a CAGR of 4.2%.
- In 2022, the United States developed the neuroendoscopy devices business with a share of 33.7%.
- The neuroendoscopy devices market grew considerably to USD 204.4 million in 2022.
- The neuroendoscopy devices market expanded with a CAGR of 4.0% between 2018 to 2022.
- By 2033, China’s neuroendoscopy devices market is projected to develop with a CAGR of 7.4%.
- By 2033, India’s neuroendoscopy devices industry is projected to expand with a CAGR of 6.1%.
- Japan’s neuroendoscopy devices industry grew significantly, with a 5.0% share in 2022.
- Australia’s neuroendoscopy devices market is likely to expand with a CAGR of 5.4% by 2033.
- Germany’s neuroendoscopy devices business grew, with a share of 8.7% in 2022
- In 2022, based on device type, rigid neuroendoscopy dominated the market, with a share of 70.1%.
- In 2022, the hospitals’ segment led the market, with a share of 52.5%, based on end use.
Request Customization of Report: https://www.futuremarketinsights.com/customization-available/rep-gb-14926
Key Players’ Strategies and Recent Developments:
Because neuroendoscopy techniques are less invasive, the market for such devices is growing quickly. Also, increasing efforts by the main competitors in the market to introduce cutting-edge neuroendoscopy for various neurological operations promote revenue growth throughout the forecast period.
- The Axonpen System, a cutting-edge neuroendoscopy, was given the go-light by the United States Food and Drug Administration in January 2021, according to ClearMind Biomedical.
- This neuroendoscopy allows for the controlled aspiration of tissue and fluid during surgery and lighting and imaging of intracranial tissue and fluids.
- Thanks to this regulatory permission, the firm expanded its research and development skills and broadened its product offering.
- Adeor Medical AG and ClearPoint Neuro, Inc., a global therapy-enabling platform provider that offers guidance and delivery to the brain, announced their strategic alliance in August 2021.
- This relationship included ClearPoint Neuro, Inc.’s United States distribution of medical tools and supplies used in neurosurgery.
- The organization expanded its clientele and boosted sales thanks to this strategic relationship.
- Foncepi Comercial Exportadora Ltda
- B. Braun
- Karl Storz
- Olympus Corporation
- Stryker
- Medtronic
- Ackermann Instruments GmbH
- Adeor Medical AG
- Clarus Medical LLC
- Machida Endoscope
- Tonglu WANHE Medical Instrument
- Hawk
- Schindler Endoskopie Technologie GmbH
- Others
Key Segments:
By Surgery Type:
- Intraventricular
- Transcranial
- Transnasal
By Device Type:
- Rigid Neuroendoscopy
- Flexible Neuroendoscopy
By Application:
- Hospitals
- Medical Research Centers
By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East & Africa
Request Checkout Now: https://www.futuremarketinsights.com/checkout/14926
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
